Six years after regulators approved Amjevita, a biosimilar to the nation's most lucrative drug, Humira, Amgen's drug jumped on the U.S. market Jan. 31 with two list prices.

Civica has selected Ypsomed AG as its manufacturer and supplier of insulin dosing injector pens.

A federal appeals court ruled in favor of three drugmakers Jan. 30 in a case over requirements of whether they should give 340B drug pricing discounts to contract pharmacies. 

Humira, AbbVie's anti-inflammatory drug that has dozens of patents and $114 billion in U.S. sales, has a tight grasp on its market. That's soon to change, The New York Times reported Jan. 28. 

Sen. Elizabeth Warren penned a letter Jan. 25 asking the Federal Trade Commission to "closely scrutinize" two proposed pharma deals: Amgen and Horizon Therapeutics, and Indivior and Opiant. 

Two national chains will reduce operation hours at their pharmacies this spring, The Wall Street Journal reported Jan. 27. 

On Jan. 26, the FDA revoked its emergency use authorization for Evusheld, a monoclonal antibody authorized to treat COVID-19, after finding it's ineffective against about 90 percent of circulating variants. 

RescriptionTM aims to dramatically reduce the cost of prescription drugs for the state’s employers and their employees

Sinai Chicago, which represents Mount Sinai Hospital, Holy Cross Hospital, Sinai Children's Hospital and other medical organizations, partnered with CVS Health Jan. 26 to join the latter's Community Equity Alliance. 

The FDA's advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option.

The launch of new biosimilars and an uptick in drugmaker transactions are expected to make waves in the pharmaceutical industry over the coming months, Moody's Investment Service said in a quarterly healthcare report issued Jan. 24.

Pharmacy technicians have the highest paychecks of all hospital work settings, but most of them aren't working in hospitals, according to the Bureau of Labor Statistics. 

Walgreens Boots Alliance is weighing whether to sell its pharmacy automation business, which is worth $2 billion, people familiar with the matter told Bloomberg. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

The updated COVID-19 vaccines' effectiveness between BA.5 and XBB subvariants are similar, according to CDC data published Jan. 25. 

Cleveland Clinic's Jeff Rosner doubts RxPass, Amazon Pharmacy's new $5 prescription subscription service, will make waves.

Kroger Health, the national grocery chain's healthcare division, will set up clinical trial sites for research on colorectal cancer gut and immune health with the aim of developing personalized medicines. 

Thirty-two lobbying groups representing the pharmaceutical industry spent more than $2 million in 2022, Politico reported Jan. 24. 

Dramatic weight-loss results from drugs such as Ozempic, Wegovy and Mounjaro are joining a less-desired outcome: a deflation in the face, The New York Times reported Jan. 24. 

Phoenix Children's, a two-hospital pediatric system, partnered with Shields Health Solutions Jan. 24 to help design and implement its specialty pharmacy program.